Anthony Lucci

12PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPsychosocial aspects of childbirth and perinatal mental healthMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Oct 27, 2026
Characterization of CTC-HER2 Status in Patients with HER2-Low Invasive Breast Cancer.

|Oct 28, 2025
Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a.

Atilla Soran, Berk Göktepe, Berkay Demirors

|Oct 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease).

Bora Lim, Angela Marx, Megumi Kai

|Sep 12, 2025
Impact of Postpartum Diagnosis on Survival of Women with Inflammatory Breast Cancer.

Jennifer H Chen, Rebecca S Slack Tidwell, Megumi Kai

|Jun 26, 2025
A Pragmatic Grouping Model for Bone-Only De Novo Metastatic Breast Cancer (MetS Protocol MF22-03).

Berk Goktepe, Berkay Demirors, Kazim Senol

|Jul 29, 2023
Presence of Circulating Tumor Cells Predates Imaging Detection of Relapse in Patients with Stage III Melanoma.

Anthony Lucci, Sridevi Addanki, Yi-Ju Chiang

Pageof 2

Frequent Collaborators

3 joint publications

Salyna Meas

2 joint publications

Bora Lim

2 joint publications

Efe Sezgin

2 joint publications

Kazım Senol